2m 2m 2m 2m 2m 2m 2m
OLEMA PHARMA (OLMA)
NASDAQ
$10.68-$0.01 (-0.14%)
Price as of Aug 21, 2026 7:43 PM EDT- $935.3MMarket Cap
- 85.59%1-Year Change
- BiotechnologyIndustry
OLEMA PHARMA (OLMA)
$10.68-$0.01 (-0.14%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FMR LLC | 13.90% | 12.1M | +1.8M (+14.46%) | Jun 30, 2026 |
PARADIGM BIOCAPITAL ADVISORS LP | 9.93% | 8.7M | +650,000 (+7.50%) | Jun 30, 2026 |
JANUS HENDERSON GROUP PLC | 8.14% | 7.1M | +398,294 (+5.60%) | Mar 31, 2026 |
JUPITER TOPCO LLC | 8.12% | 7.1M | +7.1M (+100.00%) | Jun 30, 2026 |
N/A | 8.12% | 7.1M | +7.1M (+100.00%) | Jun 30, 2026 |
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 8.11% | 7.1M | -387,989 (-5.48%) | Jun 30, 2026 |
BLACKROCK, INC. | 7.69% | 6.7M | +1.1M (+15.82%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 3.44% | 3.0M | +340,315 (+11.31%) | Mar 31, 2026 |
SPDR SERIES TRUST | 2.83% | 2.5M | 0 (0.00%) | Apr 30, 2026 |
FIDELITY SELECT PORTFOLIOS | 2.44% | 2.1M | +85,000 (+3.99%) | May 31, 2026 |
FIDELITY SECURITIES FUND | 1.82% | 1.6M | +236,600 (+14.88%) | Apr 30, 2026 |
FIDELITY ADVISOR SERIES VII | 1.75% | 1.5M | +74,400 (+4.87%) | Apr 30, 2026 |
Fidelity Rutland Square Trust II | 1.36% | 1.2M | +132,700 (+11.18%) | May 31, 2026 |
JANUS INVESTMENT FUND | 1.11% | 966,612 | -931 (-0.10%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions1.1B (85.61%)
- Mutual Funds163.9M (12.67%)
- Insiders22.3M (1.72%)
- Other0 (0.00%)
Insider Transactions
- 1.72% (22.3M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 5Number of InsiderSelling (last 12 months)
- $168.8MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Graham G. Walmsley | Award | Jun 18, 2026 | $0.00 | 29,500 | $0.00 | 29,500 |
Larson Yi | Award | Jun 18, 2026 | $0.00 | 29,500 | $0.00 | 29,500 |
BVF PARTNERS L P/IL | Award | Jun 18, 2026 | $0.00 | 29,500 | $0.00 | 29,500 |
BUTITTA CYNTHIA M | Award | Jun 18, 2026 | $0.00 | 29,500 | $0.00 | 29,500 |
CLARK IAN T | Award | Jun 18, 2026 | $0.00 | 29,500 | $0.00 | 29,500 |
Harmon Cyrus | Award | Jun 18, 2026 | $0.00 | 29,500 | $0.00 | 29,500 |
Mitchell Shawnte CHIEF LEGAL OFFICER | Exempt | Mar 04, 2026 | $0.00 | 25,000 | $0.00 | 410,000 |
Mitchell Shawnte CHIEF LEGAL OFFICER | Exempt | Mar 04, 2026 | $109,250.00 | 25,000 | $4.37 | 25,000 |
Mitchell Shawnte CHIEF LEGAL OFFICER | Sell | Mar 04, 2026 | $600,599.75 | 24,767 | $24.25 | 233 |
Mitchell Shawnte CHIEF LEGAL OFFICER | Sell | Mar 04, 2026 | $5,752.77 | 233 | $24.69 | 0 |
Mitchell Shawnte CHIEF LEGAL OFFICER | Exempt | Mar 03, 2026 | $65,550.00 | 15,000 | $4.37 | 15,000 |
Mitchell Shawnte CHIEF LEGAL OFFICER | Sell | Mar 03, 2026 | $345,150.00 | 15,000 | $23.01 | 0 |
Mitchell Shawnte CHIEF LEGAL OFFICER | Exempt | Mar 03, 2026 | $0.00 | 15,000 | $0.00 | 435,000 |
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Award | Feb 02, 2026 | $0.00 | 250,000 | $0.00 | 250,000 |
Zojwalla Naseem CHIEF MEDICAL OFFICER | Award | Feb 02, 2026 | $0.00 | 250,000 | $0.00 | 250,000 |
Mitchell Shawnte CHIEF LEGAL OFFICER | Award | Feb 02, 2026 | $0.00 | 220,000 | $0.00 | 220,000 |
Bohen Sean PRESIDENT AND CEO | Award | Feb 02, 2026 | $0.00 | 850,000 | $0.00 | 850,000 |
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Award | Feb 02, 2026 | $0.00 | 106,250 | $0.00 | 106,250 |
Zojwalla Naseem CHIEF MEDICAL OFFICER | Award | Feb 02, 2026 | $0.00 | 106,250 | $0.00 | 106,250 |
Mitchell Shawnte CHIEF LEGAL OFFICER | Award | Feb 02, 2026 | $0.00 | 56,250 | $0.00 | 56,250 |
Bohen Sean PRESIDENT AND CEO | Award | Feb 02, 2026 | $0.00 | 275,000 | $0.00 | 275,000 |
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | Sell | Jan 15, 2026 | $2.9M | 100,000 | $28.73 | 139,727 |
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Exempt | Jan 14, 2026 | $0.00 | 50,000 | $0.00 | 50,000 |
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Exempt | Jan 14, 2026 | $243,500.00 | 50,000 | $4.87 | 592,761 |
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sell | Jan 14, 2026 | $428,914.20 | 14,997 | $28.60 | 577,764 |
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sell | Jan 14, 2026 | $1.0M | 35,003 | $28.99 | 542,761 |
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | Sell | Jan 13, 2026 | $107,054.22 | 3,822 | $28.01 | 239,727 |
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Exempt | Jan 13, 2026 | $0.00 | 50,000 | $0.00 | 100,000 |
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Exempt | Jan 13, 2026 | $243,500.00 | 50,000 | $4.87 | 592,761 |
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | Sell | Jan 13, 2026 | $1.4M | 49,800 | $27.60 | 542,961 |